FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043456764> ?p ?o ?g. }

• W3043456764 abstract "Abstract Background Despite evidence of a quite large beneficial effect of endovascular treatment (EVT) for ischemic stroke caused by anterior circulation large vessel occlusion, many patients do not recover even after complete recanalization. To some extent, this may be attributable to incomplete microvascular reperfusion, which can possibly be improved by antiplatelet agents and heparin. It is unknown whether periprocedural antithrombotic medication in patients treated with EVT improves functional outcome. The aim of this study is to assess the effect of acetylsalicylic acid (ASA) and unfractionated heparin (UFH), alone, or in combination, given to patients with an ischemic stroke caused by an intracranial large vessel occlusion in the anterior circulation during EVT. Methods MR CLEAN-MED is a multicenter phase III trial with a prospective, 2 × 3 factorial randomized, open label, blinded end-point (PROBE) design, which aims to enroll 1500 patients. The trial is designed to evaluate the effect of intravenous ASA (300 mg), UFH (low or moderate dose), both or neither as adjunctive therapy to EVT. We enroll adult patients with a clinical diagnosis of stroke (NIHSS ≥ 2) and with a confirmed intracranial large vessel occlusion in the anterior circulation on CTA or MRA, when EVT within 6 h from symptom onset is indicated and possible. The primary outcome is the score on the modified Rankin Scale (mRS) at 90 days. Treatment effect on the mRS will be estimated with ordinal logistic regression analysis, with adjustment for main prognostic variables. Secondary outcomes include stroke severity measured with the NIHSS at 24 h and at 5–7 days, follow-up infarct volume, symptomatic intracranial hemorrhage (sICH), and mortality. Discussion Clinical equipoise exists whether antithrombotic medication should be administered during EVT for a large vessel occlusion, as ASA and/or UFH may improve functional outcome, but might also lead to an increased risk of sICH. When one or both of the study treatments show the anticipated effect on outcome, we will be able to improve outcome of patients treated with EVT by 5%. This amounts to more than 50 patients annually in the Netherlands, more than 1800 in Europe, and more than 1300 in the USA. Trial registration ISRCT, ISRCTN76741621 . Dec 6, 2017." @default.
• W3043456764 created "2020-07-23" @default.
• W3043456764 creator A5006225939 @default.
• W3043456764 creator A5008698288 @default.
• W3043456764 creator A5013933042 @default.
• W3043456764 creator A5024309954 @default.
• W3043456764 creator A5026647662 @default.
• W3043456764 creator A5030705633 @default.
• W3043456764 creator A5048297907 @default.
• W3043456764 creator A5049064550 @default.
• W3043456764 creator A5052180742 @default.
• W3043456764 creator A5063013324 @default.
• W3043456764 creator A5067039906 @default.
• W3043456764 creator A5079930755 @default.
• W3043456764 creator A5081542140 @default.
• W3043456764 creator A5084860153 @default.
• W3043456764 creator A5089033425 @default.
• W3043456764 date "2020-07-14" @default.
• W3043456764 modified "2023-10-15" @default.
• W3043456764 title "Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design" @default.
• W3043456764 cites W1498265361 @default.
• W3043456764 cites W1503609683 @default.
• W3043456764 cites W1755991024 @default.
• W3043456764 cites W1969661146 @default.
• W3043456764 cites W1980369396 @default.
• W3043456764 cites W1994791493 @default.
• W3043456764 cites W2014796100 @default.
• W3043456764 cites W2017781392 @default.
• W3043456764 cites W2034329675 @default.
• W3043456764 cites W2045819100 @default.
• W3043456764 cites W2050880768 @default.
• W3043456764 cites W2051824928 @default.
• W3043456764 cites W2058046969 @default.
• W3043456764 cites W2058384458 @default.
• W3043456764 cites W2061638485 @default.
• W3043456764 cites W2067436359 @default.
• W3043456764 cites W2070279796 @default.
• W3043456764 cites W2080504768 @default.
• W3043456764 cites W2105181404 @default.
• W3043456764 cites W2115218353 @default.
• W3043456764 cites W2117855158 @default.
• W3043456764 cites W2122965762 @default.
• W3043456764 cites W2128757394 @default.
• W3043456764 cites W2137001905 @default.
• W3043456764 cites W2139621750 @default.
• W3043456764 cites W2146307187 @default.
• W3043456764 cites W2153792869 @default.
• W3043456764 cites W2159689462 @default.
• W3043456764 cites W2161272496 @default.
• W3043456764 cites W2161963192 @default.
• W3043456764 cites W2164763924 @default.
• W3043456764 cites W2198398064 @default.
• W3043456764 cites W2255677352 @default.
• W3043456764 cites W2274451292 @default.
• W3043456764 cites W2277258071 @default.
• W3043456764 cites W2284249910 @default.
• W3043456764 cites W2292308933 @default.
• W3043456764 cites W2473786944 @default.
• W3043456764 cites W2547704365 @default.
• W3043456764 cites W2550364274 @default.
• W3043456764 cites W2574716662 @default.
• W3043456764 cites W2575677038 @default.
• W3043456764 cites W2736038609 @default.
• W3043456764 cites W2750489964 @default.
• W3043456764 cites W2761249896 @default.
• W3043456764 cites W2770749894 @default.
• W3043456764 cites W2776578159 @default.
• W3043456764 cites W2790691884 @default.
• W3043456764 cites W2800285152 @default.
• W3043456764 cites W2883861999 @default.
• W3043456764 cites W2920912113 @default.
• W3043456764 cites W2954004935 @default.
• W3043456764 cites W2960982617 @default.
• W3043456764 cites W2980815438 @default.
• W3043456764 cites W4236805817 @default.
• W3043456764 cites W4255683973 @default.
• W3043456764 cites W96597366 @default.
• W3043456764 doi "https://doi.org/10.1186/s13063-020-04514-9" @default.
• W3043456764 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7362523" @default.
• W3043456764 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32665035" @default.
• W3043456764 hasPublicationYear "2020" @default.
• W3043456764 type Work @default.
• W3043456764 sameAs 3043456764 @default.
• W3043456764 citedByCount "19" @default.
• W3043456764 countsByYear W30434567642021 @default.
• W3043456764 countsByYear W30434567642022 @default.
• W3043456764 countsByYear W30434567642023 @default.
• W3043456764 crossrefType "journal-article" @default.
• W3043456764 hasAuthorship W3043456764A5006225939 @default.
• W3043456764 hasAuthorship W3043456764A5008698288 @default.
• W3043456764 hasAuthorship W3043456764A5013933042 @default.
• W3043456764 hasAuthorship W3043456764A5024309954 @default.
• W3043456764 hasAuthorship W3043456764A5026647662 @default.
• W3043456764 hasAuthorship W3043456764A5030705633 @default.
• W3043456764 hasAuthorship W3043456764A5048297907 @default.
• W3043456764 hasAuthorship W3043456764A5049064550 @default.
• W3043456764 hasAuthorship W3043456764A5052180742 @default.
• W3043456764 hasAuthorship W3043456764A5063013324 @default.
• W3043456764 hasAuthorship W3043456764A5067039906 @default.
• W3043456764 hasAuthorship W3043456764A5079930755 @default.

• next